Patients with diabetes and low-income benefit from a layperson-delivered telephone-based empathetic engagement ... Patients (N=260) aged 21 years and older with diabetes and at least 1 glycated ...
Thomas W. LeBlanc, MD, MA, discusses how erythroid maturation agents (EMAs), such as luspatercept, are increasingly important in the anemia management landscape for low-risk myelodysplastic syndromes ...
Sep. 12, 2024 — Researchers have found that being a carrier for sickle cell disease, known as having sickle cell trait, increases the risk of blood clots, a risk that is the same among diverse ...